This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zunker, P. Articles by Ringelstein, E. B. Search for Related Content PubMed PubMed Citation Articles by Zunker, P. Articles by Ringelstein, E. B. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetes High Blood Pressure

(Stroke. 1996;27:219-223.)
© 1996 American Heart Association, Inc.

Articles

Hyperinsulinism and Cerebral Microangiopathy

Peter Zunker, MD; Achim Schick; Hans-Christian Buschmann; Dimitrios Georgiadis, MD; Darius G. Nabavi, MD; Michael Edelmann, MD E. Bernd Ringelstein, MD

From the Department of Neurology, University of Münster (Germany).

Correspondence to Peter Zunker, MD, Department of Neurology, University of Münster, Albert-Schweitzer-Str 33, D-48129 Münster, Germany.

Background and Purpose High insulin levels are a recognized risk factor for atherosclerosis. Microvascular endothelium is more susceptible to metabolic and mitogenic effects of insulin than large-vessel endothelium. Besides their atherogenic effect, high insulin levels impair fibrinolysis by enhancing plasminogen activator inhibitor–1. We undertook this study to evaluate the hypothesis that elevated serum insulin and C-peptide levels are related to cerebral small-vessel disease rather than large-vessel pathology.

Methods One hundred ninety-four consecutive patients presenting with symptomatic cerebrovascular disease were assigned to three subgroups that were differentiated by clinical presentations, brain imaging studies, and extracranial as well as transcranial vascular ultrasound findings: (1) patients with lacunes (n=20), (2) patients with subcortical arteriosclerotic encephalopathy (n=35), and (3) patients with strokes due to large-vessel disease (n=99). Patients who had suffered a cryptogenic (n=9) or cardioembolic (n=16) stroke or who showed characteristics of the microangiopathy and macroangiopathy groups (n=15) were not further evaluated. Thirty patients without manifestations of cerebrovascular disease were also examined. Fasting blood glucose, insulin, and C-peptide levels were determined in all subjects.

Results There were no significant differences in age or sex among the three groups and control patients. Insulin levels were significantly higher in the lacunar group compared with the subcortical arteriosclerotic encephalopathy group, the macroangiopathy group, and the control patients (median [interquartile range]: 103.8 [198.6], 72.0 [103.2], 66.0 [57.0], and 52.2 [57.0] pmol/L, respectively; all P<.05, Mann-Whitney test). There was a statistically significant difference in insulin concentrations between the microangiopathy group (subcortical arteriosclerotic encephalopathy and lacunes) and the macroangiopathy and control groups (81.0 [110.4], 66.0 [57.0], and 55.2 [57.0] pmol/L, respectively; all P<.05, Mann-Whitney). The same was true for the distribution of C-peptide levels and to a minor extent blood glucose values, but these differences failed to reach statistical significance.

Conclusions Elevated insulin levels potentially represent a pathogenetic factor in the development of cerebral small-vessel disease, predominantly in patients presenting with lacunes. Whether this is due solely to atherosclerotic changes of the small penetrating arteries or whether changes in hemorheology are operative as well remains to be evaluated.

Key Words: atherosclerosis • small vessel disease • lacunar infarction • insulin

This article has been cited by other articles:

				W T. Cade Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting Physical Therapy, November 1, 2008; 88(11): 1322 - 1335. [Abstract] [Full Text] [PDF]

				T. Ohira, E. Shahar, L. E. Chambless, W. D. Rosamond, T. H. Mosley Jr, and A. R. Folsom Risk Factors for Ischemic Stroke Subtypes: The Atherosclerosis Risk in Communities Study Stroke, October 1, 2006; 37(10): 2493 - 2498. [Abstract] [Full Text] [PDF]

				K. Kario, T. Matsuo, H. Kobayashi, S. Hoshide, and K. Shimada Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects J. Am. Coll. Cardiol., March 1, 2001; 37(3): 871 - 877. [Abstract] [Full Text] [PDF]

				Y. Tanizaki, Y. Kiyohara, I. Kato, H. Iwamoto, K. Nakayama, N. Shinohara, H. Arima, K. Tanaka, S. Ibayashi, and M. Fujishima Incidence and Risk Factors for Subtypes of Cerebral Infarction in a General Population : The Hisayama Study Stroke, November 1, 2000; 31(11): 2616 - 2622. [Abstract] [Full Text] [PDF]

				C. M. Burchfiel, D. S. Sharp, J. D. Curb, B. L. Rodriguez, R. D. Abbott, R. Arakaki, and K. Yano Hyperinsulinemia and Cardiovascular Disease in Elderly Men : The Honolulu Heart Program Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 450 - 457. [Abstract] [Full Text] [PDF]

				S. Evers, H.-G. Koch, K.-H. Grotemeyer, B. Lange, T. Deufel, and E.-B. Ringelstein Features, Symptoms, and Neurophysiological Findings in Stroke Associated With Hyperhomocysteinemia Arch Neurol, October 1, 1997; 54(10): 1276 - 1282. [Abstract] [PDF]